Correlation Between Unidentified Bright Objects on Brain Magnetic Resonance Imaging (MRI) and Cerebral Glucose Metabolism in Patients with Neurofibromatosis Type 1 |
Sohn, Young Bae
(Department of Medical Genetics, Ajou University Hospital, Ajou University School of Medicine)
An, Young Sil (Department of Nuclear Medicine, Ajou University Hospital, Ajou University School of Medicine) Lee, Su Jin (Department of Nuclear Medicine, Ajou University Hospital, Ajou University School of Medicine) Choi, Jin Wook (Department of Radiology, Ajou University Hospital, Ajou University School of Medicine) Jeong, Seon-Yong (Department of Medical Genetics, Ajou University Hospital, Ajou University School of Medicine) Kim, Hyon-Ju (Department of Medical Genetics, Ajou University Hospital, Ajou University School of Medicine) Ko, Jung Min (Department of pediatrics, Seoul National University Hospital) |
1 | Moore BD, Slopis JM, Schomer D, Jackson EF, Levy BM. Neuropsychological significance of areas of high signal intensity on brain MRIs of children with neurofibromatosis. Neurology 1996;46:1660-8. DOI ScienceOn |
2 | Goh WH, Khong PL, Leung CS, Wong VC. T2-weighted hyperintensities (unidentified bright objects) in children with neurofibromatosis1: their impact on cognitive function. J Child Neurol 2004;19:853-8. DOI |
3 | North K. Neurofibromatosis type 1. Am J Med Genet 2000;97:119-27. DOI ScienceOn |
4 | Szudek J, Friedman JM. Unidentified bright objects associated with features of neurofibromatosis 1. Pediatr Neurol 2002;27:123-7. DOI ScienceOn |
5 | North K, Hyman S, Barton B. Cognitive deficits in neurofibromatosis 1. J Child Neurol 2002;17:605-12; discussion 27-9, 46-51. DOI ScienceOn |
6 | Buchert R, von Borczyskowski D, Wilke F, Gronowsky M, Friedrich RE, Brenner W, et al. Reduced thalamic 18F-flurodeoxyglucose retention in adults with neurofibromatosis type 1. Nucl Med Commun 2008;29:17-26. DOI ScienceOn |
7 | Balestri P, Lucignani G, Fois A, Magliani L, Calistri L, Grana C, et al. Cerebral glucose metabolism in neurofibromatosis type 1 assessed with [18F]-2-fluoro-2-deoxy-D-glucose and PET. J Neurol Neurosurg Psychiatry 1994;57:1479-83. DOI ScienceOn |
8 | Bennett MR, Rizvi TA, Karyala S, McKinnon RD, Ratner N. Aberrant growth and differentiation of oligodendrocyte progenitors in neurofibromatosis type 1 mutants. J Neurosci 2003;23:7207-17. |
9 | Daginakatte GC, Gianino SM, Zhao NW, Parsadanian AS, Gutmann DH. Increased c-Jun-NH2-kinase signaling in neurofibromatosis-1 heterozygous microglia drives microglia activation and promotes optic glioma proliferation. Cancer Res 2008;68:10358-66. DOI ScienceOn |
10 | Williams VC, Lucas J, Babcock MA, Gutmann DH, Korf B, Maria BL. Neurofibromatosis type 1 revisited. Pediatrics 2009;123:124-33. DOI ScienceOn |
11 | Barbier C, Chabernaud C, Barantin L, Bertrand P, Sembely C, Sirinelli D, et al. Proton MR spectroscopic imaging of basal ganglia and thalamus in neurofibromatosis type 1: correlation with T2 hyperintensities. Neuroradiology 2011;53:141-8. |
12 | Huson SM, Harper PS, Compston DA. Von Recklinghausen neurofibromatosis. A clinical and population study in south-east Wales. Brain 1988;111:1355-81. DOI ScienceOn |
13 | DiPaolo DP, Zimmerman RA, Rorke LB, Zackai EH, Bilaniuk LT, Yachnis AT. Neurofibromatosis type 1: pathologic substrate of high-signalintensity foci in the brain. Radiology 1995;195:721-4. DOI |
14 | Moharir M, London K, Howman-Giles R, North K. Utility of positron emission tomography for tumour surveillance in children with neurofibromatosis type 1. Eur J Nucl Med Mol Imaging 2010;37:1309-17. DOI ScienceOn |
15 | Griffiths PD, Blaser S, Mukonoweshuro W, Armstrong D, Milo- Mason G, Cheung S. Neurofibromatosis bright objects in children with neurofibromatosis type 1: a proliferative potential? Pediatrics 1999;104:e49. DOI ScienceOn |
16 | Margari L, Presicci A, Ventura P, Maria Bacca S, Iliceto G, Medicamento N, et al. Clinical and instrumental (magnetic resonance imaging [MRI] and multimodal evoked potentials) follow-up of brain lesions in three young patients with neurofibromatosis 1. J Child Neurol 2006;21:1085-90. DOI |
17 | North KN, Riccardi V, Samango-Sprouse C, Ferner R, Moore B, Legius E, et al. Cognitive function and academic performance in neurofibromatosis. 1: consensus statement from the NF1 Cognitive Disorders Task Force. Neurology 1997;48:1121-7. DOI ScienceOn |
![]() |